ACTO (Analytics) — Funding, Investors & Signals 2026

ACTO

Field Force Effectiveness in Biopharma

Founded 2014 Canada

Toronto, Canada 98 employees Series B Total: $67.10M Analytics, Education +4

ACTO is a Canadian startup founded in 2014 with the slogan "Field Force Effectiveness in Biopharma." The company offers an AI-powered Intelligent Field Excellence platform tailored for the Life Sciences industry. This platform aims to enhance customer engagement and brand performance by empowering Sales, Marketing, and Medical teams. The platform's focus is on transforming field professionals into "Masters of the Message," ensuring that they engage with healthcare professionals and their support teams with authority and impact. The solution provided by ACTO equips biopharmaceutical companies to guarantee the competence, confidence, and credibility of their field professionals, enabling them to deliver the correct message to healthcare professionals during face-to-face interactions. Furthermore, ACTO provides senior leaders and frontline managers with valuable insights to drive continuous field force effectiveness. The startup operates in the Education, Health Care, and SaaS industries. Most recently, ACTO secured an $18.00M Series B investment on July 7, 2022, with funding from a consortium of investors including Panache Ventures, MaRS IAF, Salesforce Ventures, Questa Capital, and Resolve Growth Partners.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$18.00M	5	Panache Ventures, MaRS IAF +3	07 Jul 2022
Series A	$11.50M	3	Panache Ventures, Salesforce Ventures +1	27 Aug 2020
Seed Round	$900.00K	-		18 Jan 2018
Seed Round	$1.20M	6	Panache Ventures, MaRS IAF +4	15 Aug 2017
Non Equity Assistance	Undisclosed	1	VentureOut	13 Aug 2017
Angel Round	$500.00K	1	China Canada Angel Alliance	01 Jan 2016
Pre Seed Round	Undisclosed	1	DMZ	01 Jan 2015
Series B	CNY25.00M	1	Infotech Ventures	01 Oct 2008
Series A	CNY10.00M	1	Shenzhen Capital Group	01 Jan 2001

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$18.00M

Panache Ventures, MaRS IAF +3

07 Jul 2022

Series A

$11.50M

Panache Ventures, Salesforce Ventures +1

27 Aug 2020

Seed Round

$900.00K

18 Jan 2018

Seed Round

$1.20M

Panache Ventures, MaRS IAF +4

15 Aug 2017

Non Equity Assistance

Undisclosed

VentureOut

13 Aug 2017

Angel Round

$500.00K

China Canada Angel Alliance

01 Jan 2016

Pre Seed Round

Undisclosed

DMZ

01 Jan 2015

Series B

CNY25.00M

Infotech Ventures

01 Oct 2008

Series A

CNY10.00M

Shenzhen Capital Group

01 Jan 2001

FAQ About ACTO

Field Force Effectiveness in Biopharma

ACTO was founded in 2014.

ACTO is headquartered in Toronto, Canada.

ACTO operates in Analytics, Education, Health Care, Life Sciences, SaaS and Machine Learning. Its work centres on Sales Training, Commercialization, Life Sciences and Sales Enablement.

ACTO has approximately 98 employees.

ACTO has completed 9 funding rounds, raising a total of $67.10M. The latest funding stage is Series B.

Top alternatives and competitors to ACTO include Rehearsal, ysura GmbH, Enoch®, Rehab Essentials, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ACTO and Rehearsal are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

ACTO

General Information

Discover More

About ACTO

Funding Rounds & Investors (9)

Latest News

ACTO Alternatives & Competitors

FAQ About ACTO